134 related articles for article (PubMed ID: 17624450)
21. [Chemical constituents of Rhodiola kirilowii (Regel) Regel].
Peng JN; Ma CY; Ge YC
Zhongguo Zhong Yao Za Zhi; 1994 Nov; 19(11):676-7, 702. PubMed ID: 7893386
[TBL] [Abstract][Full Text] [Related]
22. [Establishment and the significance of a cell model of secreted alkaline phosphatase co-controlled by HCV 5'NCR and NS3 serine protease].
Liu SP; Tan DM; Yang YF; Hou ZH
Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):552-3. PubMed ID: 15387910
[TBL] [Abstract][Full Text] [Related]
23. Development and application of a fast, reproducible assay to measure HCV NS3 protease activity using Escherichia coli lysate.
Han B; Dvory-Sobol H; Greenstein A; McCarville JF; Hung M; Liu X; Miller MD; Mo H
J Virol Methods; 2015 Dec; 225():76-86. PubMed ID: 26391876
[TBL] [Abstract][Full Text] [Related]
24. [Preliminary screening of activity fraction of Alchornea trewioides suppresses expression of subgenomic hepatitis C virus RNA in vitro].
Wang QR; Tao HM; Wu G; Fan Q; Huang SH; Hong F; Lv ZP
Zhong Yao Cai; 2013 Jun; 36(6):880-3. PubMed ID: 24380267
[TBL] [Abstract][Full Text] [Related]
25. Discovery of a series of novel compounds with moderate anti-hepatitis C virus NS3 protease activity in vitro.
Shi F; Zhang Y; Xu W
Bioorg Med Chem; 2015 Sep; 23(17):5539-45. PubMed ID: 26238980
[TBL] [Abstract][Full Text] [Related]
26. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
[TBL] [Abstract][Full Text] [Related]
27. The design of a potent inhibitor of the hepatitis C virus NS3 protease: BILN 2061--from the NMR tube to the clinic.
Tsantrizos YS
Biopolymers; 2004; 76(4):309-23. PubMed ID: 15386268
[TBL] [Abstract][Full Text] [Related]
28. HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen.
Gal-Tanamy M; Zemel R; Berdichevsky Y; Bachmatov L; Tur-Kaspa R; Benhar I
J Mol Biol; 2005 Apr; 347(5):991-1003. PubMed ID: 15784258
[TBL] [Abstract][Full Text] [Related]
29. Potent inhibitors of the hepatitis C virus NS3 protease: use of a novel P2 cyclopentane-derived template.
Johansson PO; Bäck M; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
Bioorg Med Chem; 2006 Aug; 14(15):5136-51. PubMed ID: 16675222
[TBL] [Abstract][Full Text] [Related]
30. In Vitro Activity of Simeprevir against Hepatitis C Virus Genotype 1 Clinical Isolates and Its Correlation with NS3 Sequence and Site-Directed Mutants.
Verbinnen T; Fevery B; Vijgen L; Jacobs T; De Meyer S; Lenz O
Antimicrob Agents Chemother; 2015 Dec; 59(12):7548-57. PubMed ID: 26392483
[TBL] [Abstract][Full Text] [Related]
31. Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins.
Massariol MJ; Zhao S; Marquis M; Thibeault D; White PW
Biochem Biophys Res Commun; 2010 Jan; 391(1):692-7. PubMed ID: 19944069
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antiviral activity of HCV NS3/4A peptidomimetic boronic acid inhibitors.
Boloor A; Hanway D; Joshi M; Winn DT; Mendez G; Walls M; Wei P; Qian F; Zhang X; Zhang Y; Hepperle ME; Li X; Campbell DA; Betancort JM
Bioorg Med Chem Lett; 2009 Oct; 19(19):5708-11. PubMed ID: 19713109
[TBL] [Abstract][Full Text] [Related]
33. Identification of non-macrocyclic small molecule inhibitors against the NS3/4A serine protease of hepatitis C virus through in silico screening.
Chaudhuri R; Lee H; Truong L; Torres J; Patel K; Johnson ME
J Chem Inf Model; 2012 Aug; 52(8):2245-56. PubMed ID: 22697413
[TBL] [Abstract][Full Text] [Related]
34. Mapping natural polymorphisms of hepatitis C virus NS3/4A protease and antiviral resistance to inhibitors in worldwide isolates.
López-Labrador FX; Moya A; Gonzàlez-Candelas F
Antivir Ther; 2008; 13(4):481-94. PubMed ID: 18672527
[TBL] [Abstract][Full Text] [Related]
35. Development of a cell-based assay for monitoring hepatitis C virus ns3/4a protease activity.
Lei YF; Yin W; Yang J; Lv X; Wei SH; An QX; Hu XB; Xu ZK
Acta Virol; 2008; 52(3):133-41. PubMed ID: 18999887
[TBL] [Abstract][Full Text] [Related]
36. Improved P2 phenylglycine-based hepatitis C virus NS3 protease inhibitors with alkenylic prime-side substituents.
Lampa A; Ehrenberg AE; Gustafsson SS; Vema A; Kerblom E; Lindeberg G; Karlén A; Danielson UH; Sandström A
Bioorg Med Chem; 2010 Jul; 18(14):5413-24. PubMed ID: 20541424
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effects of polyphenols toward HCV from the mangrove plant Excoecaria agallocha L.
Li Y; Yu S; Liu D; Proksch P; Lin W
Bioorg Med Chem Lett; 2012 Jan; 22(2):1099-102. PubMed ID: 22196120
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors.
Sheng XC; Pyun HJ; Chaudhary K; Wang J; Doerffler E; Fleury M; McMurtrie D; Chen X; Delaney WE; Kim CU
Bioorg Med Chem Lett; 2009 Jul; 19(13):3453-7. PubMed ID: 19477126
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups.
Li X; Liu Y; Zhang YK; Plattner JJ; Baker SJ; Bu W; Liu L; Zhou Y; Ding CZ; Zhang S; Kazmierski WM; Hamatake R; Duan M; Wright LL; Smith GK; Jarvest RL; Ji JJ; Cooper JP; Tallant MD; Crosby RM; Creech K; Wang A
Bioorg Med Chem Lett; 2012 Dec; 22(24):7351-6. PubMed ID: 23142614
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HCV replicon cell growth by 2-arylbenzofuran derivatives isolated from Mori Cortex Radicis.
Lee HY; Yum JH; Rho YK; Oh SJ; Choi HS; Chang HB; Choi DH; Leem MJ; Choi EJ; Ryu JM; Hwang SB
Planta Med; 2007 Nov; 73(14):1481-5. PubMed ID: 17948170
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
